UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000054822 |
|---|---|
| Receipt number | R000062644 |
| Scientific Title | A scoping review of factors influencing activated clotting time results and measurement differences among Instruments |
| Date of disclosure of the study information | 2024/06/29 |
| Last modified on | 2024/06/30 12:11:28 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
A scoping review of factors influencing activated clotting time results and measurement differences among Instruments
Acronym
A scoping review of factors influencing activated clotting time results and measurement differences among Instruments
Scientific Title
A scoping review of factors influencing activated clotting time results and measurement differences among Instruments
Scientific Title:Acronym
A scoping review of factors influencing activated clotting time results and measurement differences among Instruments
Region
| Japan |
Condition
Condition
Disease/situation requiring measurement of activated clotting time
Classification by specialty
| Medicine in general | Cardiology | Nephrology |
| Vascular surgery | Emergency medicine | Intensive care medicine |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
The purpose of this scoping review is to get a complete picture of previous reports on factors influencing ACT measurement results, differences in measurement results among instruments, and relationships with APTT.
Basic objectives2
Others
Basic objectives -Others
None
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Previous reports on factors influencing ACT measurement results, differences in measurement results by instrument, and relationship with APTT
Key secondary outcomes
Base
Study type
Others,meta-analysis etc
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
We will retrieve relevant articles in MEDLINE (PubMed) using "activated clotting time" as a keyword. Clinical trials, observational studies and, in vitro experiments with human blood will be included.
Key exclusion criteria
Animal studies, case reports, and review articles will be excluded.
Target sample size
Research contact person
Name of lead principal investigator
| 1st name | Mineji |
| Middle name | |
| Last name | Hayakawa |
Organization
Hokkaido University Hospital
Division name
Emergency and Critical Care Center
Zip code
060-8648
Address
North 14-West5, Kita-ku, Sapporo
TEL
011-706-7377
mineji@dream.com
Public contact
Name of contact person
| 1st name | Mineji |
| Middle name | |
| Last name | Hayakawa |
Organization
Hokkaido University Hospital
Division name
Emergency and Critical Care Center
Zip code
060-8648
Address
North 14-West 5, Kita-ku, Sapporo
TEL
011-707-7377
Homepage URL
mineji@dream.com
Sponsor or person
Institute
Hokkaido university
Institute
Department
Personal name
Funding Source
Organization
None
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Ethical Review Board for Life Science and Medical Research, Hokkaido University Hospital
Address
North 14-West 5, Kita-ku, Sapporo
Tel
011-706-7636
crjimu@huhp.hokudai.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2024 | Year | 06 | Month | 29 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2024 | Year | 07 | Month | 01 | Day |
Date of IRB
Anticipated trial start date
| 2024 | Year | 07 | Month | 01 | Day |
Last follow-up date
| 2025 | Year | 07 | Month | 01 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
We will retrieve relevant articles in MEDLINE (PubMed) using "activated clotting time" as a keyword on July 1, 2024.
Management information
Registered date
| 2024 | Year | 06 | Month | 29 | Day |
Last modified on
| 2024 | Year | 06 | Month | 30 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062644
